EnsoData leverages artificial intelligence to automate waveform analysis and uncover disease processes across various timescales, ranging from heart rhythm irregularities to glycemic index dynamics and sleep disorder breathing patterns. Their AI-powered software services deliver significant cost and time savings for clinicians, enabling better patient care and outcomes. Their first solution, EnsoSleep, focuses on sleep medicine to reduce sleep study scoring time and improve diagnostic workflows.

EnsoData is dedicated to making healthcare more accurate, efficient, and affordable by harnessing the power of AI technology. They aim to support frontline clinicians by automating repetitive data annotation tasks and accelerating diagnosis and treatment workflows. The company emphasizes a hospitable culture symbolized by the pineapple, reflecting their commitment to collaboration, diversity, equity, and inclusion within their team and client relationships.

EnsoData's AI solutions primarily address the vast undiagnosed sleep apnea population with FDA-cleared products such as EnsoSleep PPG and EnsoSleep, integrating seamless diagnosis to therapy for sleep disorders.